tolbutamide has been researched along with glucagon-like peptide 1 (7-36) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobashi, Y; Kanno, T; Nakano, K; Suga, S; Takeo, T; Wakui, M | 1 |
| Ding, WG; Kitasato, H; Matsuura, H | 1 |
2 other study(ies) available for tolbutamide and glucagon-like peptide 1 (7-36)
| Article | Year |
|---|---|
GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Barium; Bucladesine; Calcium Channels; Calcium Channels, L-Type; Cells, Cultured; Cyclic AMP; Electric Stimulation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Islets of Langerhans; Kinetics; Membrane Potentials; Peptide Fragments; Rats; Thionucleotides; Tolbutamide | 1997 |
Involvement of calmodulin in glucagon-like peptide 1(7-36) amide-induced inhibition of the ATP-sensitive K+ channel in mouse pancreatic beta-cells.
Topics: Adenosine Triphosphate; Animals; Calcium; Calmodulin; Electrophysiology; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Hypoglycemic Agents; Imidazoles; Islets of Langerhans; Male; Membrane Potentials; Mice; Mice, Inbred ICR; Peptide Fragments; Potassium Channels; Sulfonamides; Tolbutamide | 2001 |